Kyverna Therapeutics
KYTX
#8475
Rank
NZ$0.49 B
Marketcap
NZ$7.79
Share price
-2.52%
Change (1 day)
-38.33%
Change (1 year)

EPS for Kyverna Therapeutics (KYTX)

EPS in 2026 (TTM): NZ-$5.10

According to Kyverna Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$5.37. In 2025 the company made an earnings per share (EPS) of NZ-$6.67.

EPS history for Kyverna Therapeutics from 2025 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.10-23.5%
2025NZ-$6.67